Has Sohrab Virk, MD received payments from drug or device companies?

Yes. Drug and device makers reported $75,527 in general payments to Sohrab Virk, MD across 120 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sohrab Virk, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sohrab Virk, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sohrab Virk, MD

Surgery · New York, NYNPI 1013270230

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $46,064 of the $75,527 with a category attached, or 61.0%. Life Spine, Inc. accounts for 68.2% of it on its own, with 17 other manufacturers making up the rest. Among surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$75,527in general payments, 2019–2025

Across 120 payments — averaging $629.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Life Spine, Inc.$52K
Arteriocyte Medical Systems, Inc.$14K
MML US, Inc.$2K
Alphatec Spine, Inc$2K
Stryker$2K
Medtronic$1K
plus $2K from 12 others

$107,947in research payments, 2019–2025

Across 24 payments — averaging $4497.79 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

MML US, Inc.$108K
Medtronic$25

What the payments were for

Consulting fees$46,06461%
Speaking & faculty fees$10,00013%
Travel & lodging$13,36818%
Food & beverage$6,0958%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Life Spine, Inc.	47	$51,511
Arteriocyte Medical Systems, Inc.	3	$13,715
MML US, Inc.	15	$2,424
Alphatec Spine, Inc	8	$2,266
Stryker	11	$1,819
Medtronic(2 entities)	12	$1,326
Globus Medical(2 entities)	9	$1,194
Orthofix Medical, Inc.	3	$437
Spineology Inc.	1	$188
Zimvie Inc.	1	$139
Kuros Biosciences USA, Inc	1	$127
AbbVie	1	$122
Amplify Surgical, Inc.	2	$87
Locate Bio Inc	1	$65
Medical Device Business Services, Inc.	2	$39
Polaris Technology Solutions LLC	1	$25
Pacira Pharmaceuticals Incorporated	1	$21
Si-bone, Inc.	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ProLift Micro$29,698
ProLift Micro Tube Access$19,386
Influx$13,611
ReActiv8$2,181
Other - Miscellaneous$2,172
EVEREST SPINAL SYSTEM$1,330
ARx$1,230
AVATAR MINIMALLY INVASIVE SPINAL SYSTEM$720
PRO-LINK STAND-ALONE CERVICAL SPACER SYSTEM$656
MAZOR X SYSTEM$566
GRUVE ANTERIOR CERVICAL PLATE System$482
Calypso Retractor$482
CENTRIC - T RETRACTOR$482
Centerline Thoracolumbar Spinal System$482
XLIF$462
Spinal-Stim$315
ProLift$303
RELINE$286
Pulse$234
O-ARM-Spine$192

How this compares

$75,527 in reported general payments places this provider in the 95th percentile of 1,596 surgery providers in New York.

See all surgery providers in New York →

Medicare billing

Part B allowed, 2024

$521,061

Medicare patients

681

Services billed

2,409

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tizanidine Hcl	516	$2,950
Diclofenac Sodium	307	$2,226
Lidocaine	21	$1,682
Gabapentin	149	$891
Meloxicam	131	$278
Prednisone	44	$165
Mupirocin	17	$146
Pantoprazole Sodium	27	$108
Ibuprofen	19	$97
Cyclobenzaprine Hcl	12	$69
Methylprednisolone	12	$65

Paid to pharmacies, not to this prescriber.

Other surgery in New York

Cheguevara AfanehNew York$1.4M
Flavio Malcher Martins de OliveiraNew York$695K
Yuri NovitskyNew York$548K
Rasa ZarnegarNew York$478K
Tanuja DamaniNew York$459K
Rache SimmonsNew York$371K
Marina KurianNew York$328K
Megan JenkinsNew York$290K
Brian JacobNew York$225K
Robin BlackstoneNew York$174K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →